HOME > MARKETS > MARKET COMMENTARY
  MARKET COMMENTARY
EQUITY
Shilpa Medicare shines on the BSE
Jul-11-2025

Shilpa Medicare is currently trading at Rs. 906.80, up by 36.10 points or 4.15% from its previous closing of Rs. 870.70 on the BSE.

The scrip opened at Rs. 886.00 and has touched a high and low of Rs. 914.20 and Rs. 871.25 respectively. So far 18684 shares were traded on the counter.

The BSE group 'T' stock of face value Rs. 1 has touched a 52 week high of Rs. 1003.20 on 16-Jun-2025 and a 52 week low of Rs. 530.50 on 07-Apr-2025.

Last one week high and low of the scrip stood at Rs. 915.95 and Rs. 841.25 respectively. The current market cap of the company is Rs. 8740.55 crore.

The promoters holding in the company stood at 44.23%, while Institutions and Non-Institutions held 18.52% and 37.25% respectively.

Shilpa Medicare has received GMP certification from Saudi Food and Drug Authority (SFDA), Saudi Arabia, for its Unit VI facility, located at Dabaspet, Bengaluru. This follows the on-site inspection of this site from February 18 to February 20, 2025, which was closed with ZERO observations. This was a full GMP inspection of entire facility with specific focus on Ondansetron Oral Film drug product.

This facility of the company is engaged in the manufacture, testing, storage and release of finished dosage forms in the category of Oral Films and Transdermal Patches. Oral Films are currently being supplied from this site to US, Australia and other Emerging countries. The site is approved by European Medicine Agency, Europe following a recent inspection by Finnish regulators.

Shilpa Medicare produces and exports consistently high-quality Active Pharmaceutical Ingredients Fine Chemicals, intermediates, herbal products and speciality chemical products using sophisticated technology, meticulously following international specifications.

  RELATED NEWS >>